The Cigna Group Common Stock (CI)
Stock · NYSE · Health Care
$302.33as of 10/16/2026
Price chart
Active signals
CI Signal Track Record
How signals performed across all stocks →What CI's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 39 | +1.1% | 64% | September 18, 2026 |
| 200-Day Moving Average TouchActive now | 30 | -1.6% | 40% | October 7, 2026 |
| Bollinger Band Breakdown | 22 | +0.7% | 55% | September 23, 2026 |
| Bollinger Band BreakoutActive now | 18 | -0.4% | 50% | September 3, 2026 |
| Any 20-session window (baseline) | +0.9% | 56% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CI
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benef…
- Sector
- Health Care
- Industry
- Medical Specialities
- Employees
- 65,669
- Website
- www.thecignagroup.com/
Fundamentals
- 1-day range
- $293.17$300.11
- Market cap
- $72.73B
- P/E (trailing)
- 12.15
- P/E (forward)
- 8.92
- EPS (trailing)
- $24.13
- Dividend yield
- 1.74%
- Beta
- 0.26
- Avg. volume
- 1.68M
- Ex-dividend date
- September 8, 2026
- Dividend pay date
- September 23, 2026
How The Cigna Group Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 26, 2026 · via SEC EDGAR / Finnhub
Forecasts
24 analyst ratings
The Cigna Group Common Stock Competitors
Chosen by industry and closest market cap.
- CIThe Cigna Group Common Stock$302.3▲ 1.17%Market cap $72.73BP/E 12.15$239.51$311.34
- ELVElevance Health Inc. Common Stock$428.26▼ 0.04%Market cap $84.88BP/E 18.75$274.84$436.24
- HUMHumana Inc. Common Stock$413.16▼ 4.41%Market cap $44.10BP/E 39.25$163.11$456.5
- NTRANatera Inc. Common Stock$393.44▼ 2.80%Market cap $38.01BP/E —$170.82$437.41
- CNCCentene Corporation Common Stock$69.16▼ 1.91%Market cap $31.71BP/E —$31.63$70.37
- ILMNIllumina Inc. Common Stock$262.54▼ 2.01%Market cap $29.25BP/E 48.62$88$309.35
- DGXQuest Diagnostics Incorporated Common Stock$235▼ 1.74%Market cap $26.32BP/E 24.67$171.18$248.84
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CI The Cigna Group Common Stock | $72.73B | 12.15 | $302.3 | ▲ 1.17% | $239.51$311.34 |
| ELV Elevance Health Inc. Common Stock | $84.88B | 18.75 | $428.26 | ▼ 0.04% | $274.84$436.24 |
| HUM Humana Inc. Common Stock | $44.10B | 39.25 | $413.16 | ▼ 4.41% | $163.11$456.5 |
| NTRA Natera Inc. Common Stock | $38.01B | — | $393.44 | ▼ 2.80% | $170.82$437.41 |
| CNC Centene Corporation Common Stock | $31.71B | — | $69.16 | ▼ 1.91% | $31.63$70.37 |
| ILMN Illumina Inc. Common Stock | $29.25B | 48.62 | $262.54 | ▼ 2.01% | $88$309.35 |
| DGX Quest Diagnostics Incorporated Common Stock | $26.32B | 24.67 | $235 | ▼ 1.74% | $171.18$248.84 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- CVS Health (CVS) vs Cigna (CI): Which is a Better Stock to Buy?Yahoo · 10/9/2026
- The Cigna Group's Third Quarter 2026 Earnings Release DetailsYahoo · 10/9/2026
- Humana Reaffirms FY26 Adjusted EPS Guidance Of At Least $9; Exceeding Goal Of Top Quartile Results In 2027 Medicare Advantage Star Ratings; Expects 2028 Benefit For One-Time Investments And Return To ShareholdersBenzinga · 10/9/2026
- CMS Releases 2027 Medicare Advantage And Part D Star Ratings, With 37% Of MA-PD Contracts Earning Four Or More Stars And 71% Of Enrollees In High-Rated PlansBenzinga · 10/8/2026
- Cigna Healthcare Introduces Health Sense To Connect Guidance, Benefits and Clinical Support Around Each Person, Improving Affordability and OutcomesYahoo · 10/6/2026
- Robert Kennedy Jr. Pushes New Healthcare Pricing Rules as HHS Says Patients Deserve Clearer Costs: ‘Americans Should Know…’benzinga · 10/6/2026
- Robert Kennedy Jr. Pushes New Healthcare Pricing Rules as HHS Says Patients Deserve Clearer Costs: ‘Americans Should Know…’Benzinga · 10/6/2026
- 2 Safe-and-Steady Stocks with Promising Prospects and 1 We Turn DownYahoo · 10/5/2026
- UnitedHealth Group: Getting Cheaper And CheaperSeekingAlpha · 10/5/2026
Insider Activity
Insider Actions →- Everett Neville · September 3, 2026 · Sale617 @ $284.05
- Brian C. Evanko · September 1, 2026 · Grant3.1K
- Brian C. Evanko · September 1, 2026 · Grant6.7K
- George Kurian · August 31, 2026 · Grant109 @ $276.08
- Nicole S. Jones · August 18, 2026 · Sale2.7K @ $279.61
- Holgerson Bryan · August 6, 2026 · Grant1 @ $275.25
- Nicole S. Jones · August 5, 2026 · Option Exercise1.3K @ $192.02
- Nicole S. Jones · August 4, 2026 · Option Exercise14.0K @ $192.02
- Nicole S. Jones · August 4, 2026 · Sale19.4K @ $276.27
- Holgerson Bryan · July 23, 2026 · Grant1 @ $286.29
- Holgerson Bryan · July 9, 2026 · Grant1 @ $291.8
- Jamie G. Kates · June 12, 2026 · Option Exercise899 @ $152.89
- Jamie G. Kates · June 12, 2026 · Sale899 @ $298.61
- Durga Prasad Koka · June 1, 2026 · Tax Withholding729 @ $275.53
- George Kurian · May 29, 2026 · Grant108 @ $277.4
Institutional Ownership
March 31, 2026
- Total shares held
- 225.40M
- Total value held
- $58.09B
- Institutional holders
- 1635
- Unknown22.60M
- Unknown17.12M
- Unknown12.28M
- Unknown11.60M
- Unknown11.56M
- Unknown10.96M
- Unknown10.29M
- Unknown6.20M
- Unknown6.00M
- Unknown3.43M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Cigna Shifts Strategy Toward Health Technology With Health Sense Initiative
Cigna is repositioning its competitive advantage through the Health Sense platform, signaling a move toward data-driven care delivery. The company's trailing P/E of 12.1 and 1.74% dividend yield highlight its value profile. Analysts project an average target of $342.29, while the 52-week range spans $239.51 to $311.34. Current support at $279.02 has seen 11 touches, suggesting caution ahead of potential moves.
Cigna Shifts Strategy Toward Health Technology With Health Sense Initiative. Cigna is repositioning its competitive advantage through the Health Sense platform, signaling a move toward data-driven care delivery. The company's trailing P/E of 12.1 and 1.74% dividend yield highlight its value profile. Analysts project an average target of $342.29, while the 52-week range spans $239.51 to $311.34. Current support at $279.02 has seen 11 touches, suggesting caution ahead of potential moves.